SEC Form 4/A · accession 0001209191-18-045267
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
J Scott Wolchko
Officer — President and CEO · Director
Period of report
Jul 18, 2018
Accepted (ET)
Aug 3, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3,F2 | $11.03 | Jul 18, 2018 | A | 152,000 | A | — | Jul 17, 2028 | Common Stock | 152,000 | 152,000 | D |
Explanation of responses
- F1The number of shares reported on this amended Form 4 reflects the correct number of shares underlying the stock option granted to Mr. Wolchko on July 18, 2018.
- F2The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on August 18, 2018 such that this option is fully exercisable on July 18, 2022.
- F3Not applicable.